ERK/GATAD2A/SAA1 axis drives osimertinib resistance via NF-κB and macrophage reprogramming in EGFR-mutated lung adenocarcinoma
Journal of Experimental & Clinical Cancer Research
Scope & Focus
Medicine
About This Journal
Authors: Junkan Zhu, Shencheng Ren, Tao Cheng, Guangyao Shan et al.
DOI: 10.1186/s13046-026-03792-6
Ready to Submit?
You will be directed to the journal website where you can review submission guidelines and submit your manuscript.
Visit Journal Website →